Inhibition of Experimental Liver Cirrhosis in Mice by Telomerase Gene Delivery
Data up to Jan 2025
Total Citations Per Year
Abstract
References (59)
Telomeres shorten during ageing of human fibroblasts
1990 • 5,530 citations
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
1998 • 4,845 citations
A simplified system for generating recombinant adenoviruses
1998 • 3,179 citations
Creation of human tumour cells with defined genetic elements
1999 • 2,333 citations
Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
1997 • 2,086 citations
TRF2 Protects Human Telomeres from End-to-End Fusions
1998 • 1,679 citations
THE STABILITY OF BROKEN ENDS OF CHROMOSOMES IN ZEA MAYS
1941 • 1,586 citations
The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies
1993 • 1,444 citations
Longevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice
1999 • 1,326 citations
Essential role of mouse telomerase in highly proliferative organs
1998 • 1,256 citations
Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells
1998 • 1,206 citations
Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span
1998 • 1,001 citations
p53 Deficiency Rescues the Adverse Effects of Telomere Loss and Cooperates with Telomere Dysfunction to Accelerate Carcinogenesis
1999 • 969 citations
Developmental and tissue-specific regulation of mouse telomerase and telomere length.
1995 • 686 citations
Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry
1998 • 561 citations
Telomerase, Cell Immortality, and Cancer
1994 • 405 citations
Evidence for a Critical Telomere Length in Senescent Human Fibroblasts
1995 • 391 citations
Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene
1991 • 387 citations
Short Dysfunctional Telomeres Impair Tumorigenesis in the INK4aΔ2/3 Cancer-Prone Mouse
1999 • 373 citations
Book Review Ethical Problems in Dialysis and Transplantation (Developments in Nephrology. Vol. 33.) Edited by Carl M. Kjellstrand and John B. Dossetor. 235 pp., illustrated. Boston, Kluwer Academic, 1992. $108.50. 0-7923-1625-8
1993 • 329 citations
Is Cirrhosis of the Liver Experimentally Produced by Cc14 An Adequate Model of Human Cirrhosis?
1983 • 320 citations
Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas.
1995 • 313 citations
Activation of telomerase in a human tumor.
1994 • 289 citations
Progressive Telomere Shortening in Aplastic Anemia
1998 • 271 citations
Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease.
1991 • 266 citations
The morphology of cirrhosis: definition, nomenclature, and classification.
1977 • 243 citations
Regulation of signal transduction during liver regeneration
1996 • 228 citations
Neonatal bleeding in transgenic mice expressing urokinase-type plasminogen activator
1990 • 223 citations
Transforming growth factor—beta 1 (TGF-β1) and TGF-β1 receptors in normal, cirrhotic, and neoplastic human livers
1995 • 219 citations
Block in Anaphase Chromosome Separation Caused by a Telomerase Template Mutation
1997 • 204 citations
Pathogenesis of Liver Fibrosis
1997 • 176 citations
Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis
1997 • 174 citations
Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease
1997 • 160 citations
Severe growth defect in mouse cells lacking the telomerase RNA component
1998 • 159 citations
Telomere Shortening in Chronic Liver Diseases
1995 • 142 citations
Telomerase in human development and cancer
1997 • 139 citations
The roles of telomeres and telomerase in cell life span
1996 • 137 citations
Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes.
1994 • 130 citations
Role of transforming growth factor ? type II receptor in hepatic fibrosis: Studies of human chronic hepatitis C and experimental fibrosis in rats
1999 • 107 citations
Telomere stability is frequently impaired in high-risk groups of patients with myelodysplastic syndromes.
1999 • 99 citations
Telomere length in human liver diseases
1996 • 85 citations
Differential regulation of extracellular matrix synthesis during liver regeneration after partial hepatectomy in rats
1999 • 83 citations
Relationship between hepatocyte proliferative activity and liver functional reserve in human cirrhosis
1996 • 76 citations
Immunosenescence in HIV Pathogenesis
1997 • 73 citations
Relationship between hepatocyte proliferative activity and liver functional reserve in human cirrhosis
1996 • 72 citations
Changes in Telomerase Activity and Telomere Length during Human T Lymphocyte Senescence
1997 • 67 citations
Organ variation in the mutagenicity of MeIQ in Big Blue® lacI transgenic mice
1996 • 55 citations
Quantitation of telomerase activity in hepatocellular carcinoma: A possible aid for a prediction of recurrent diseases in the remnant liver
1998 • 51 citations
Effects of TGF‐βs in the Liver: Cell Proliferation and Fibrogenesis
2007 • 40 citations
The telomere and telomerase: how Do they interact?
2000 • 37 citations
Factors in recent reductions in liver cirrhosis deaths.
1991 • 35 citations
Liver cirrhosis
1998 • 34 citations
Chromosomal Instability and Telomere Length Variations during the Life Span of Human Fibroblast Clones
1997 • 31 citations
Changes in liver cirrhosis death rates in different countries in relation to per capita alcohol consumption and Alcoholics Anonymous membership.
1998 • 28 citations
Telomerase activity and telomere length in human hepatocellular carcinoma
1998 • 28 citations
Telomerase is strongly activated in hepatocellular carcinoma but not in chronic hepatitis and cirrhosis
1998 • 27 citations
Increased CD4+ T‐Lymphocyte Senescence Fraction in Advanced Human Immunodeficiency Virus Type 1 Infection
1999 • 26 citations
DOES INCREASED SPENDING ON ALCOHOLISM TREATMENT LEAD TO LOWER CIRRHOSIS DEATH RATES?
1996 • 17 citations
[Telomere length and telomerase activity in hepatocellular carcinoma].
1998 • 4 citations